Phenotypes of resistance to the macrolide-lincosamide-ketolide-streptogramin (MLKS) group of antibiotics have been determined in 540 clinical isolates of staphylococci (210 Staphylococcus aureus and 330 coagulase-negative species). Results of disc diffusion tests using erythromycin A, oleandomycin, rokitamycin, clindamycin, telithromycin, quinupristin and dalfopristin delineated four main groups corresponding to those defined classically using erythromycin and clindamycin only, but with sub-divisions. Resistance to erythromycin was more common in coagulase-negative strains (56%) than in S. aureus (16%); telithromycin, clindamycin, quinupristin-dalfopristin and rokitamycin were active against >97% of S. aureus strains and >88% of the coagulase-negative strains. The commonest resistance phenotype was 'inducible MLS B ' (12% in S. aureus, 31% in coagulase-negative strains); this group could be divided in terms of the different inducing abilities of erythromycin and oleandomycin. 'Constitutive MLS B ' and 'MS' phenotypes were more often found in coagulase-negative strains (11 and 13%, respectively) than in S. aureus (2 and 1%). Novel phenotypes were found during the isolation of constitutively resistant mutants from inducible strains, and of resistant mutants from 'MS' strains. This extended phenotyping scheme has revealed further complexities and evolutionary possibilities in patterns of resistance to this group of antibiotics.
Introduction
Interest in the macrolide antibiotics has increased greatly during the last decade. This was a consequence firstly of chemical modifications to the ring structure of erythromycin A resulting in newer macrolides such as azithromycin, clarithromycin and roxithromycin, 1, 2 and secondly of the synthesis of the ketolides, 3 in which significant alterations have been made to the sugar side chains. The newer macrolides have remarkable pharmacokinetic properties, enlarging their spectrum compared with the archetypal macrolide erythromycin A, but all the resistance mechanisms that operate against the latter also apply to the former. Thus, there is complete cross-resistance. On the other hand, ketolides do not induce the enzyme responsible for the most common form of resistance to erythromycin, the so-called 'inducible MLS B ' phenotype. 4 Therefore ketolides, in contrast to the newer macrolides, remain active against many erythromycin-resistant strains. 5 The purpose of the present study was to determine the incidence of various types of erythromycin resistance among a large number of unselected staphylococci isolated from patients in a university hospital, and to investigate how these resistance mechanisms affected susceptibility to antibiotics related to erythromycin A, namely another 14-membered macrolide (oleandomycin), a 16-membered macrolide (rokitamycin), a lincosamide (clindamycin), a ketolide (telithromycin) and representatives of the A and B components of the streptogramins (quinupristin and dalfopristin), alone and in combination.
Materials and methods

Bacterial strains
Staphaurex. CNS were identified where appropriate using API Staph kits.
The origin of each strain was checked by patient's name and hospital number, and possible duplicate strains excluded. For the methicillin-resistant strains, only one of each clonal type was included in the test population.
Antibiotics
Telithromycin (HMR 3647) was given by Hoechst Marion Roussel (Romainville, France); Synercid (RP 59500, seven parts quinupristin, three parts dalfopristin), dalfopristin (RP 54476) and quinupristin (RP 57669), each as the methane sulphonate, were given by Rhone-Poulenc Rorer (Collegeville, PA, USA); erythromycin BP free base was given by Lilly Industries (Basingstoke, UK); rokitamycin was given by ISF SpA (Milan, Italy); lincomycin hydrochloride and oleandomycin phosphate were purchased from Sigma (Poole, UK). Erythromycin was dissolved in ethanol, the other compounds in water.
Discs containing oleandomycin 15 g were purchased from Mast Laboratories (Bootle, UK), and erythromycin 15 g and clindamycin 2 g from Unipath Laboratories (Basingstoke, UK). Discs containing Synercid 15 g and telithromycin 15 g were given by Rhone-Poulenc Rorer R-D (Antony, France) and Hoechst Marion Roussel, respectively. Discs containing 15 g of either rokitamycin, dalfopristin or quinupristin were made as required by treating Whatman AA discs with the appropriate antibiotic solution.
Chemicals
These were obtained from Sigma (Poole, UK).
Media
Nutrient agar (NA), Mueller-Hinton agar (MHA) and broth (MHB) were from Unipath. 'Blood agar' was Columbia agar (Mast) ϩ 5% whole horse blood.
Susceptibility testing
All 540 strains were tested by the breakpoint method against erythromycin (0.5 and 4 mg/L), lincomycin (1 and 2 mg/L) and Synercid (1 mg/L), on MHA inoculated with 10 4 cfu, incubated for 24 h in air. The 215 strains resistant to erythromycin and the five sensitive to erythromycin but resistant to lincomycin were then screened by a disc diffusion method. An aqueous suspension of bacterial growth from blood agar was adjusted to McFarland 0.5, and inoculated by swab on MHA (60 L in a plate of diameter 140 mm). Each plate was set with 13 discs (centres 2 cm apart) as shown in Figure 1 . This arrangement allowed both the sensitivity pattern to individual compounds and interactions between the various antibiotics to be observed with a minimum amount of repetition.
Zone sizes and their shapes were read after overnight incubation, and then again after a further 24 h. If the nature of a specific interaction was not clear, the individual test was set up again in 90 mm plates, with the distances between discs being varied as appropriate.
Zones were interpreted according to their size and shape, as indicating sensitive or resistant, the latter being inducible if a 'D'-shaped zone was observed (the compound on the left being the inducer). Synergy was recorded if there was an extension of inhibition zone between two discs. The presence of satellite colonies within inhibition zones, and other evidence for the existence of sub-populations (e.g. some degree of 'target zone' formation) as well as unusual shapes of zones were noted.
Phenotypes were denoted by abbreviations of antibiotic class to which a strain was resistant: M, erythromycin; A, oleandomycin; L, clindamycin; S A , dalfopristin; S B , quinupristin; K, telithromycin; Mac, rokitamycin.
When resistance was inducible by erythromycin, i was prefixed. Thus, for example, the classical 'inducible MLS B ' phenotype is denoted here as M/i(LKS B Mac), and the classical 'constitutive MLS B ' phenotype is MLKS B Mac.
We also used the 13 disc method to determine the phenotypes of five strains (two MRSA, three Staphylococcus haemolyticus) that had previously shown anomalous susceptibilities to telithromycin. MIC determinations were made following the NCCLS agar dilution method. 6 
Selection of resistant mutants
Cultures in MHB were spun down and resuspended at 10ϫ original concentration. A viable count was performed, and 0.1 mL (c. 10 9 cfu) was spread on MHA containing 1.2 mg/L telithromycin (i.e. at least 20 ϫ MIC) and colonies counted after 48 h incubation. The proportion of cells able to grow was calculated, and their phenotypes determined by the 13 disc method described above.
Reversal of resistance
(i) Doubling dilutions of ethidium bromide in MHA were spot-inoculated with strains under test, and incubated overnight. For each strain, sub-culture was made from the 0.5 ϫ MIC plate on to NA, and incubated overnight. Approximately 20 colonies from these plates were spotinoculated on to MHA Ϯ erythromycin (8 mg/L ϭ c. 16 ϫ MIC for sensitive strains). Those unable to grow in the presence of erythromycin had lost their resistance; they were also tested as in second screen above.
(ii) For strains in which an efflux mechanism was suspected, the MIC of erythromycin was determined alone and in the presence of (separately) dinitrophenol (20 mg/L), reserpine (20 mg/L) and carbonyl cyanide m-chlorophenol hydrazone (0.25 mg/L). These concentrations were chosen by solubility for the first two compounds and microbiological activity for the third. A four-fold diminution in MIC was taken as indicating inhibition of efflux.
Synergy/antagonism experiments
Interactions between oleandomycin and telithromycin were investigated and analysed by chequerboard titration on MHA using doubling dilutions, as described previously. 7 Results were interpreted as 'synergy', 'antagonism' or 'indifference'. The latter term was used in the sense originally defined by Jawetz & Gunnison, 8 meaning that each antibiotic in combination behaves as if the other were not there.
Assays of antibiotic destruction
Destruction of lincomycin and clindamycin was tested for by a modified Gots test 9 read after 48 h, and measured as described by Leclercq et al. 10 For the latter test, cells from overnight cultures were concentrated 60-fold in phosphate buffer containing 20 mg/L of the antibiotic and incubated at 37°C. A similar suspension of S. aureus Oxford was tested as a negative control. Antibiotic concentrations were determined at intervals by bioassay with S. aureus Oxford as indicator.
For technical reasons it was not possible to test for dalfopristin inactivation under these conditions.
Results
Sensitivity to individual agents
Sensitivity patterns are shown in Table I . CNS were significantly more often resistant to erythromycin, telithromycin, clindamycin, quinupristin or rokitamycin than were S. aureus strains (P Ͻ 0.01 by chi-squared test). Only five strains (two Staphylococcus epidermidis, two Staphylococcus sciuri and one Staphylococcus simulans) were resistant to dalfopristin (MIC 32 or 64 mg/L). All 540 strains tested were sensitive to Synercid, despite two (the S. epidermidis mentioned above, nos 152 and 538) being resistant to both components (Figure 2 ).
Type of resistance to erythromycin
The most common type of resistance to erythromycin was the 'inducible' variety (Table II) ; the 'constitutive' and 'MS' types were less common, especially among S. aureus strains. The incidence of all three types was higher among CNS than for S. aureus (P Ͻ 0.01). 
943
Resistance phenotypes to MLKSMac antibiotics
Results obtained by analysing patterns of resistance deduced from the 13 disc screening test defined four groups, each of which could be divided into two.
Group A: destructive mechanism. Five of the 540 staphylococcal strains tested were resistant to lincomycin although sensitive to erythromycin. This pattern suggested the possible presence of a drug inactivation mechanism. 11 More detailed investigations of these strains showed this to be the case (Table III) : the two S. epidermidis strains, phenotype L (group A 1 ), inactivated clindamycin rapidly and lincomycin more slowly, while the other three strains, phenotype LS A , did not inactivate lincosamides.
The anomaly of strains rapidly inactivating clindamycin but being sensitive to the antibiotic has been reported previously. 10 Group B: classical inducible 'MLS B '. The 129 strains in this category (26 S. aureus, 103 CNS) were resistant to erythromycin and oleandomycin, and sensitive to clindamycin, telithromycin, quinupristin, dalfopristin and rokitamycin. For several strains, satellite colonies were observed in the truncated part of the zone between the erythromycin and clindamycin discs (e.g. as in Figure 1 ).
Strains could be divided into two groups on the basis of the inducing behaviour of erythromycin and oleandomycin. In organisms in group B 1 (15 S. aureus, 99 CNS), resistance to clindamycin, telithromycin, quinupristin and rokitamycin was induced by erythromycin and by oleandomycin.
The 15 strains in group B 2 (11 S. aureus, two S. haemolyticus, two S. simulans) were induced by erythromycin, but oleandomycin either did not induce (Figure 3) or had a variable effect, inducing resistance to some but not all of the agents depending on the strain. There was a disproportionate number of S. aureus strains in group B 2 -73% compared with 20.1% in group B overall. All the group B strains had the phenotype M/i(LKS B Mac).
Group C: classical constitutive 'MLS B '. Forty strains (five S. aureus, 35 CNS) with the phenotype MLKS B Mac were classified as group C 1 . Two other strains (S. epidermidis nos 152 and 538) were also resistant to dalfopristin (phenotype MLKS AB Mac); they were classified as group C 2 .
A zone of inhibition shaped like a shield ( Figure 4 ) was seen when dalfopristin and quinupristin were tested side by side against group C 1 strains. The enhanced area of inhibition between the discs represents synergy between dalfopristin and quinupristin, despite the strains being resistant to the latter. The five strains from our previous study that appeared constitutively resistant by conventional testing showed two further, novel, phenotypes. The two MRSA strains were ML (we have also seen this phenotype in diphtheroids, unpublished observations), and the three S. haemolyticus were MLS A /i(KS B ). We have called these phenotypes C 3 and C 4 , respectively.
Group D: efflux mechanisms. Forty-six strains (two S. aureus, 44 CNS) were resistant to erythromycin and there was no induction of resistance to clindamycin. This pattern suggests 'active efflux'. 11 In the CNS strains, resistance to telithromycin and to quinupristin was induced by either erythromycin or oleandomycin, giving a phenotype of M/i(KS B ); these were designated group D 1 . In the S. aureus strains, however, no such induction occurred; these therefore had phenotype M, and were assigned to group D 2 . Seventeen strains (nine S. aureus, eight CNS) were grown in the presence of ethidium bromide: clones sensitive to all MLKSMac antibiotics were isolated from one S. aureus and one S. haemolyticus.
Further investigations on strains of different phenotypes Inducibly resistant strains (group B).
The interactions between oleandomycin and telithromycin against B 2 strains were further investigated by the chequerboard method. For three strains (S. simulans nos 190 and 416, and S. haemolyticus no. 29), antagonism was found; for four (S. aureus nos 212, 342, 482 and 545) there was synergy; against the remaining eight strains each antibiotic behaved as if the other was not there ('indifference'). These results can be correlated with MICs of oleandomycin (Table IV) B 2 strains were less resistant to oleandomycin than to erythromycin (Table IV) , and several showed a small zone of inhibition around the oleandomycin disc. The 'trailing endpoint' observed for erythromycin in the B 2 strains (Table IV) suggests some degree of heterogeneity. In contrast to the B 2 strains, fully sensitive strains were more sensitive to erythromycin than to oleandomycin, while B 1 strains grew in the presence of 128 mg/L of either macrolide.
Constitutively resistant strains (group C)
. Nine strains with constitutive resistance grown in the presence of ethidium bromide retained their phenotype.
Strains with efflux mechanisms. MICs were determined for 18 D 1 strains and the two D 2 strains (Table V) . Six strains of the former sub-group and one of the latter (S. aureus no. 514) were plated on to agar containing 20 ϫ MIC of telithromycin. Telithromycin-resistant colonies were found only from S. aureus no. 514; these were also resistant to quinupristin. Thus, a change of phenotype from M to MS B K had occurred.
Compounds reported to be inhibitors of efflux pumps (reserpine, dinitrophenol and carbonylcyanide m-chlorophenyl hydrazone) had no effect on MIC of erythromycin against the 18 D 1 strains (results not shown). However, for the two D 2 strains S. aureus nos 321 and 514, dinitrophenol (but not the other compounds) reduced the MIC of erythromycin at least four-fold (to 32 and 2 mg/L, respectively).
Discussion
The availability of newer macrolides has resulted in greater use of this group of compounds, and this has, not surpris- a Erythromycin showed a 'trailing end-point'. The first figure is the concentration at which heavy growth turns into light growth, the second figure where light growth stops. MRSA, methicillin-resistant Staphylococcus aureus. Although most attention has been paid in this respect to streptococci, it is clear that staphylococci have also been affected. In three recent studies 12-14 the incidences of resistance to erythromycin in S. aureus strains from Europe were 13-30%, and in the USA 20-50%. Most surveys 13, [15] [16] [17] report that, as we found, CNS were more likely to be resistant than S. aureus. The situation in this hospital has changed since our last survey:
18 (i) the overall incidence of resistance to erythromycin in S. aureus has increased fivefold (from 3 to 15.7%), and the constitutive MLS B phenotype has appeared in methicillin-sensitive S. aureus; (ii) in CNS, although the overall incidence of resistance is virtually unchanged (55% compared with 61%) and the MLS B phenotype is still more frequently inducible than constitutive, the MS phenotype, absent previously, now makes up almost one-quarter of the resistant strains.
As expected, there was complete cross-resistance between the two 14-membered macrolides erythromycin and oleandomycin, while telithromycin, the 16-membered rokitamycin, clindamycin and quinupristin remained active against all but the strains with a constitutive MLS B phenotype. This is because the latter four compounds do not induce the staphylococcal enzyme that confers resistance by ribosomal methylation. 19 The experimental plan adopted in this investigationtesting the activities of and interactions between seven MLSK antibiotics including oleandomycin-has revealed novel phenotypes among clinical isolates and their laboratory derivatives. This further illustrates the considerable and apparently increasing complexity of resistance manifestations to this group of antibiotics, 11, [19] [20] [21] [22] [23] as well as the shortcomings of conventional phenotyping in terms of susceptibility to erythromycin and clindamycin only (Table VI) .
Phenotype A
Staphylococci of phenotype LS A are unusual, and have previously been found mainly in S. aureus [24] [25] [26] and only where pristinamycin has been used clinically. 27 The three CNS strains found in the present study (two S. sciuri and one S. simulans) add to the six (four S. sciuri, two S. haemolyticus) reported previously. 27, 28 Recent work 29 on S. sciuri suggests that this species is usually intrinsically resistant to dalfopristin, showing the LS A phenotype.
Phenotype B
The behaviour of oleandomycin as an inducing agent enabled strains traditionally allotted to the 'inducible MLS B ' phenotype to be split into two groups. Despite having the same phenotype-M/i(LKS B Mac)-strains in group B 2 were less highly resistant to erythromycin than were group B 1 strains: none grew at 128 mg/L, and trailing end-points suggested heterogeneity. In contrast both to erythromycin-sensitive strains and B 1 strains, B 2 strains were more susceptible to oleandomycin than to erythromycin, and often showed a small zone of inhibition around the oleandomycin disc. Whereas erythromycin induced resistance to clindamycin, telithromycin, quinupristin and rokitamycin in all group B strains, oleandomycin did so only in group B 1 strains: there was great variability in the interaction between oleandomycin and the other antibiotics for the group B 2 strains, and synergy was observed for some with telithromycin. Japanese workers 30, 31 showed more than 30 years ago that oleandomycin and erythromycin may have different inducing abilities for certain staphylococci, but since then this phenomenon has been largely ignored.
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Phenotype C
All the strains in this grouping would be classified as 'constitutively resistant' by conventional testing using only erythromycin and clindamycin. C 1 and C 2 strains had very similar phenotypes-MLKS B Mac and MLKS AB Mac, respectively. Another phenotype found during this investigation that would be classified loosely as 'constitutively resistant', but is in fact novel is that of the ketolide-resistant mutants selected from three S. haemolyticus strains from group B, whose phenotype was MLKMac/iS B . It should be noted, however, that the phenotype found in the majority of phenotype B strains selected with telithromycin was the classical C 1 pattern.
Phenotype D
Strains that are resistant to erythromycin and sensitive to clindamycin (no induction) have been generally called 'MS' or 'PMS' in staphylococci, 32 and 'M phenotype' or novel resistance (NR) in streptococci. 33, 34 The two S. aureus strains in this group (D 2 ) were resistant only to erythromycin and oleandomycin, in contrast to the CNS strains (D 1 ) in which resistance could be induced to quinupristin and telithromycin. Another difference was that the uncoupling agent dinitrophenol reduced the MICs of erythromycin for D 2 but not for D 1 strains.
Two additional novel phenotypes, MS B /iK in S. haemolyticus and Staphylococcus saprophyticus (both D 1 ) and MS B K in S. aureus, were produced by selection of these strains with telithromycin (Table VI) .
Ketolides, the latest members of the macrolide group, show good activity against a wide range of Gram-positive species, including important respiratory pathogens. The survey reported above shows that telithromycin, which has the advantage over the quinupristin-dalfopristin combination of being orally bioavailable, is active against the great majority of staphylococci. Adding telithromycin to the battery of tests for resistance to the MLS antibiotic group has revealed some novel phenotypes, which may be of epidemiological interest.
From a clinical viewpoint, careful monitoring must be continued to determine the incidence of constitutive resistance, as such strains are insensitive to the MLKS B antibiotics. The relative ease of selection of constitutive mutants from inducible strains (group BǞC conversion) also suggests that vigilance be exercised when novel members of this group are used to treat infections caused by inducible strains.
